BioNxt Solutions Inc.
BNXT
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -939.80K | -1.38M | -926.80K | -1.07M | -712.10K |
| Total Depreciation and Amortization | 4.90K | -4.10K | 16.30K | 16.90K | 16.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 284.90K | 755.70K | 276.00K | 331.90K | 230.10K |
| Change in Net Operating Assets | 102.00K | -292.40K | -140.20K | 557.10K | -69.10K |
| Cash from Operations | -547.90K | -916.60K | -774.80K | -169.00K | -534.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 1.30K | 58.00K | 0.00 | 0.00 | 41.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.30K | 58.00K | 0.00 | 0.00 | 41.10K |
| Total Debt Issued | 0.00 | 3.39M | 2.11M | -- | -- |
| Total Debt Repaid | -1.71M | -- | -1.03M | -- | -- |
| Issuance of Common Stock | 431.50K | 135.00K | 137.90K | 0.00 | 945.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.71M | -2.00M | -178.10K | 0.00 | -43.20K |
| Cash from Financing | 311.90K | 1.06M | 740.50K | 0.00 | 659.00K |
| Foreign Exchange rate Adjustments | 0.00 | 600.00 | 200.00 | 700.00 | 200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -234.80K | 206.80K | -34.10K | -168.30K | 165.90K |